Regardless, we should continue to renew the R13 PA-21-151.
| Route | R61/R33 |
|---|---|
| FOA Initial Title | Research Infrastructure Development for Interdisciplinary Aging Studies (R61/R33 - Clinical Trial Optional)PAR-20-070 (R61/R33) |
| FOA renewal | PAR-20-071 (R33) |
| Annual budget limit years 1-5 | $500k |
| 2022 AD/ADRD Funding Line (overall impact score) | 40 |
| Due date | July 3, 2023 |
| Earliest start date | April 2024 |
This FOA aims to provide needed resources to interdisciplinary groups that collaborate to meet the challenge of developing effective research infrastructure on important aging topics. Purpose: This FOA invites applications that propose to develop novel research infrastructure that will advance the science of aging in specific areas requiring interdisciplinary partnerships or collaborations. Scope: Applications submitted to this FOA should propose the development of research infrastructure to advance specific topics in aging science that require interdisciplinary partnerships or collaborations. The range of disciplines included in the application should be appropriate to the scientific goals of the proposed collaboration. This FOA aims to support the establishment of new interdisciplinary collaborations or the development of existing interdisciplinary collaborations in significantly new directions. For existing collaborations, reviewers will evaluate closely whether the application represents a substantial development in a scientific focus, as opposed to simply maintaining existing operations.
Research infrastructure supported through this FOA must endeavor to benefit the larger research community, as opposed to solely supporting the investigators’ research interests. It is expected that applications funded through this FOA will not only develop a research infrastructure, but also produce new knowledge, tools, or other tangible scientific results arising from specific research projects that are enabled by the new research infrastructure.
NIA Divisions and their interest in this FOA
This FOA utilizes the R61/R33 Exploratory/Developmental Phased Award activity code. The R61 phase provides up to 2 years of support for initial developmental activities. The R33 phase provides up to 3 years of support for expanded activities. Proposed projects must include both an R61 phase with milestone-driven developmental activities, and an R33 phase with milestone-driven expanded activities that will build on the initial R61 developmental phase to achieve the aims of the entire award. Milestones are required for both phases. Milestones must be specific, measurable, achievable, relevant, and time-bound (SMART). Applications that only propose R61 or R33 activities will be considered incomplete and will not be accepted. An R61/R33 award is not renewable.|
Activities of the Project
A variety of activities may be conducted within the scientific scope of this FOA. These include, but are not limited to, the following:
- Meetings of investigators and other stakeholders to identify research priorities, approaches, or other relevant objectives
- Conducting secondary analyses of existing data sets
- Developing approaches for data harmonization or standardization across different data platforms
- Merging and harmonizing data from existing longitudinal data sets, including cohorts spanning broad age ranges
- Replicating studies of key findings, including both previous findings (through new data collection or re-analyses of existing data) and pre-planned replication of findings from current or planned data collection
- Developing data-mining methodologies
- Combining existing human “omics” databases for performing integrative analyses
- Developing accessible biospecimen repositories
- Developing and validating diagnostic tests or assays; for example, to distinguish physiologic from pathologic responses or processes
- Developing platforms for integrated analysis of different morphometric, phenotypic, and omic data types from single or multiple species
- Developing and phenotyping new animal models for aging research
- Scaling up of research infrastructure
- Conducting feasibility or pilot studies of interventions
- Larger-scale testing of interventions developed in the pilot phase
- Translating screening approaches, diagnostic methods, or interventions into practice or community settings
- Sharing and disseminating data, methodology, practice guidelines, or other research products
- Providing research experiences for early career investigators
NIH Reporter searches on previous and related FOAs